Literature DB >> 19050267

A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice.

Jennifer C Miller1, Ying Ma, Jiantao Bian, Kathleen C F Sheehan, James F Zachary, John H Weis, Robert D Schreiber, Janis J Weis.   

Abstract

Gene expression analysis previously revealed a robust IFN-responsive gene induction profile that was selectively up-regulated in Borrelia burgdorferi-infected C3H mice at 1 wk postinfection. This profile was correlated with arthritis development, as it was absent from infected, mildly arthritic C57BL/6 mice. In this report we now demonstrate that profile induction in infected C3H scid mice occurs independently of B or T lymphocyte infiltration in the joint tissue. Additionally, type I IFN receptor-blocking Abs, but not anti-IFN-gamma Abs, dramatically reduced arthritis, revealing a critical but previously unappreciated role for type I IFN in Lyme arthritis development. Certain examined IFN-inducible transcripts were also significantly diminished within joint tissue of mice treated with anti-IFNAR1, whereas expression of other IFN-responsive genes was more markedly altered by anti-IFN-gamma treatment. These data indicate that induction of the entire IFN profile is not necessary for arthritis development. These findings further tie early type I IFN induction to Lyme arthritis development, a connection not previously made. Bone marrow-derived macrophages readily induced IFN-responsive genes following B. burgdorferi stimulation, and this expression required a functional type I IFN receptor. Strikingly, induction of these genes was independent of TLRs 2,4, and 9 and of the adapter molecule MyD88. These data demonstrate that the extracellular pathogen B. burgdorferi uses a previously unidentified receptor and a pathway traditionally associated with viruses and intracellular bacteria to initiate transcription of type I IFN and IFN-responsive genes and to initiate arthritis development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050267      PMCID: PMC3024833          DOI: 10.4049/jimmunol.181.12.8492

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis.

Authors:  Hillary Crandall; Diane M Dunn; Ying Ma; R Mark Wooten; James F Zachary; John H Weis; Robert B Weiss; Janis J Weis
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection.

Authors:  Kathleen C F Sheehan; Koon Siew Lai; Gavin P Dunn; Allen T Bruce; Mark S Diamond; Jennifer D Heutel; Corazon Dungo-Arthur; Javier A Carrero; J Michael White; Paul J Hertzog; Robert D Schreiber
Journal:  J Interferon Cytokine Res       Date:  2006-11       Impact factor: 2.607

Review 3.  Interferon signalling network in innate defence.

Authors:  Akinori Takaoka; Hideyuki Yanai
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

4.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Identification of genes selectively regulated by IFNs in endothelial cells.

Authors:  Stefano Indraccolo; Ulrich Pfeffer; Sonia Minuzzo; Giovanni Esposito; Valeria Roni; Susanna Mandruzzato; Nicoletta Ferrari; Luca Anfosso; Raffaella Dell'Eva; Douglas M Noonan; Luigi Chieco-Bianchi; Adriana Albini; Alberto Amadori
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 6.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

7.  Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis.

Authors:  Charles R Brown; Victoria A Blaho; Kevin L Fritsche; Christie M Loiacono
Journal:  J Interferon Cytokine Res       Date:  2006-06       Impact factor: 2.607

8.  Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue.

Authors:  M Gattorno; L Chicha; A Gregorio; F Ferlito; F Rossi; D Jarrossay; A Lanzavecchia; A Martini; M G Manz
Journal:  Rheumatology (Oxford)       Date:  2006-11-03       Impact factor: 7.580

9.  A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector.

Authors:  Katharina Ornstein; Alan G Barbour
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

10.  T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice.

Authors:  Xiaohui Wang; Ying Ma; Alyson Yoder; Hillary Crandall; James F Zachary; Robert S Fujinami; John H Weis; Janis J Weis
Journal:  FEMS Immunol Med Microbiol       Date:  2007-12-11
View more
  46 in total

1.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

Review 2.  Induction of type I interferons by bacteria.

Authors:  Kathryn M Monroe; Sarah M McWhirter; Russell E Vance
Journal:  Cell Microbiol       Date:  2010-05-06       Impact factor: 3.715

Review 3.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

4.  Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.

Authors:  F Lynn Sonderegger; Ying Ma; Heather Maylor-Hagan; James Brewster; Xiaosong Huang; Gerald J Spangrude; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

5.  Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.

Authors:  Elzbieta Jacek; Brian A Fallon; Abhishek Chandra; Mary K Crow; Gary P Wormser; Armin Alaedini
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

6.  TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi.

Authors:  Tanja Petnicki-Ocwieja; Erin Chung; David I Acosta; Laurie T Ramos; Ok S Shin; Sanjukta Ghosh; Lester Kobzik; Xin Li; Linden T Hu
Journal:  Infect Immun       Date:  2012-11-19       Impact factor: 3.441

7.  Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.

Authors:  Andrea C Love; Ira Schwartz; Mary M Petzke
Journal:  J Leukoc Biol       Date:  2014-11-24       Impact factor: 4.962

Review 8.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

9.  Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.

Authors:  Junghee J Shin; Klemen Strle; Lisa J Glickstein; Andrew D Luster; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2010-09-09       Impact factor: 5.156

10.  Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Authors:  Juan C Salazar; Star Duhnam-Ems; Carson La Vake; Adriana R Cruz; Meagan W Moore; Melissa J Caimano; Leonor Velez-Climent; Jonathan Shupe; Winfried Krueger; Justin D Radolf
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.